78

Business

Novozymes in strong first quarter showing

admin
April 24th, 2014


This article is more than 10 years old.

Novozymes is even closer to realising its long-term goal of enjoying 10 percent annual growth from 2015

The Danish biotech giant Novozymes has entered 2014 with a bang, surpassing expectations for the first quarter and subsequently raising expectations for the rest of the year.

The Bagsværd-based company enjoyed operating profit earnings before interest and taxes (EBIT) to the tune of 923 million kroner out of a turnover of 3.033 billion kroner, which is well above analyst predictions.

“We’ve delivered a strong first quarter, and we’re increasing the outlook for full-year EBIT growth,”  Peder Holk Nielsen, the head of Novozymes, said in a press release.

“Double-digit organic sales growth, a good underlying earnings performance and the completion of the BioAg Alliance agreement mark a good start to 2014.”

Novozymes now expects annual EBIT and net profit growth of 8-10 percent, as opposed to the 6-9 percent it expected at the beginning of the year, and this moves the company even closer to realising its long-term goal of enjoying 10 percent annual growth from 2015.

READ MORE: Investors avoiding Danish biotech market

US investment
In related news, Novozymes announced yesterday that it intends to invest about 195 million kroner into a new research and development centre in the US state of North Carolina over the coming three years.

The facility will focus on creating sustainable solutions for agriculture and is expected to generate 100 new jobs.

Among other things, researchers will study and develop useful micro-organisms that are already found in the earth in order to create technology that can improve crop yield, fertility and fighting pests.

Novozymes’ five primary areas of business are in bioenergy, agriculture and fodder, cleaning products, food and drink products, and technical and pharma.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”